Barinthus Biotherapeutics
BRNS
#9836
Rank
C$39.11 M
Marketcap
$0.97
Share price
-11.43%
Change (1 day)
-80.49%
Change (1 year)

Revenue for Barinthus Biotherapeutics (BRNS)

Revenue in 2024 (TTM): C$20.22 Million

According to Barinthus Biotherapeutics's latest financial reports the company's current revenue (TTM ) is C$21.28 Million. an increase over the revenue in the year 2023 that were of C$1.06 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Barinthus Biotherapeutics from 2020 to 2024

Annual revenue

Year Revenue Change
2024 C$21.48 M1919.32%
2023 C$1.06 M-98.25%
2022 C$60.65 M17660.14%
2021 C$0.34 M-94.44%
2020 C$6.14 M